MeiraGTx Holdings (MGTX) Shares Outstanding (Diluted Average) (2020 - 2025)
MeiraGTx Holdings posted quarterly Shares Outstanding (Diluted Average) of $80.4 million for Q4 2025, up 15.19% year-on-year from $69.8 million in Q4 2024, and down 0.64% on a QoQ basis from $80.9 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $80.4 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 15.19% year-over-year to $80.4 million; the trailing twelve-month figure through Dec 2025 stood at $80.4 million (up 15.19% YoY), and the FY2025 full-year result was $80.4 million, up 15.19% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2025 stood at $80.4 million, down from $80.9 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $80.9 million in Q3 2025 and bottomed at $44.0 million in Q1 2021.
- The 5-year median for Shares Outstanding (Diluted Average) is $54.2 million (2023), against an average of $58.1 million.
- The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) advanced 1.02%; it then jumped 33.41% in 2023.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $44.1 million in 2021, then gained by 2.35% to $45.2 million in 2022, then rose by 25.03% to $56.5 million in 2023, then grew by 23.61% to $69.8 million in 2024, then advanced by 15.19% to $80.4 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $80.4 million (Q4 2025), $80.9 million (Q3 2025), and $80.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 138.23 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 80.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 80.43 Mn |
| Sep 30, 2025 | 80.95 Mn |
| Jun 30, 2025 | 80.59 Mn |
| Mar 31, 2025 | 79.03 Mn |
| Dec 31, 2024 | 69.82 Mn |
| Sep 30, 2024 | 71.63 Mn |
| Jun 30, 2024 | 64.38 Mn |
| Mar 31, 2024 | 64.07 Mn |
| Dec 31, 2023 | 56.49 Mn |
| Sep 30, 2023 | 59.53 Mn |
| Jun 30, 2023 | 52.01 Mn |
| Mar 31, 2023 | 48.64 Mn |
| Dec 31, 2022 | 45.18 Mn |
| Sep 30, 2022 | 44.62 Mn |
| Jun 30, 2022 | 44.67 Mn |
| Mar 31, 2022 | 44.50 Mn |
| Dec 31, 2021 | 44.14 Mn |
| Sep 30, 2021 | 44.17 Mn |
| Jun 30, 2021 | 44.14 Mn |
| Mar 31, 2021 | 43.97 Mn |
| Sep 30, 2020 | 36.94 Mn |